478 related articles for article (PubMed ID: 22100165)
21. In-depth analysis of Kaposi's sarcoma-associated herpesvirus microRNA expression provides insights into the mammalian microRNA-processing machinery.
Umbach JL; Cullen BR
J Virol; 2010 Jan; 84(2):695-703. PubMed ID: 19889781
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus latency by virus-encoded microRNAs that target Rta and the cellular Rbl2-DNMT pathway.
Lu F; Stedman W; Yousef M; Renne R; Lieberman PM
J Virol; 2010 Mar; 84(6):2697-706. PubMed ID: 20071580
[TBL] [Abstract][Full Text] [Related]
23. HIV-1 Vpr Inhibits Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication by Inducing MicroRNA miR-942-5p and Activating NF-κB Signaling.
Yan Q; Shen C; Qin J; Li W; Hu M; Lu H; Qin D; Zhu J; Gao SJ; Lu C
J Virol; 2016 Oct; 90(19):8739-53. PubMed ID: 27440900
[TBL] [Abstract][Full Text] [Related]
24. A KSHV microRNA enhances viral latency and induces angiogenesis by targeting GRK2 to activate the CXCR2/AKT pathway.
Li W; Jia X; Shen C; Zhang M; Xu J; Shang Y; Zhu K; Hu M; Yan Q; Qin D; Lee MS; Zhu J; Lu H; Krueger BJ; Renne R; Gao SJ; Lu C
Oncotarget; 2016 May; 7(22):32286-305. PubMed ID: 27058419
[TBL] [Abstract][Full Text] [Related]
25. Understanding pathogenetic aspects and clinical presentation of primary effusion lymphoma through its derived cell lines.
Carbone A; Cesarman E; Gloghini A; Drexler HG
AIDS; 2010 Feb; 24(4):479-90. PubMed ID: 20051807
[TBL] [Abstract][Full Text] [Related]
26. A Kaposi's sarcoma-associated herpesvirus microRNA and its variants target the transforming growth factor β pathway to promote cell survival.
Lei X; Zhu Y; Jones T; Bai Z; Huang Y; Gao SJ
J Virol; 2012 Nov; 86(21):11698-711. PubMed ID: 22915806
[TBL] [Abstract][Full Text] [Related]
27. Kaposi's Sarcoma-Associated Herpesvirus MicroRNAs Target GADD45B To Protect Infected Cells from Cell Cycle Arrest and Apoptosis.
Liu X; Happel C; Ziegelbauer JM
J Virol; 2017 Feb; 91(3):. PubMed ID: 27852859
[TBL] [Abstract][Full Text] [Related]
28. microRNA dependent and independent deregulation of long non-coding RNAs by an oncogenic herpesvirus.
Sethuraman S; Gay LA; Jain V; Haecker I; Renne R
PLoS Pathog; 2017 Jul; 13(7):e1006508. PubMed ID: 28715488
[TBL] [Abstract][Full Text] [Related]
29. Convergence of Kaposi's sarcoma-associated herpesvirus reactivation with Epstein-Barr virus latency and cellular growth mediated by the notch signaling pathway in coinfected cells.
Spadavecchia S; Gonzalez-Lopez O; Carroll KD; Palmeri D; Lukac DM
J Virol; 2010 Oct; 84(20):10488-500. PubMed ID: 20686042
[TBL] [Abstract][Full Text] [Related]
30. A Kaposi's sarcoma-associated herpesvirus-encoded ortholog of microRNA miR-155 induces human splenic B-cell expansion in NOD/LtSz-scid IL2Rγnull mice.
Boss IW; Nadeau PE; Abbott JR; Yang Y; Mergia A; Renne R
J Virol; 2011 Oct; 85(19):9877-86. PubMed ID: 21813606
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus inhibits Kaposi's sarcoma-associated herpesvirus lytic replication in primary effusion lymphomas.
Xu D; Coleman T; Zhang J; Fagot A; Kotalik C; Zhao L; Trivedi P; Jones C; Zhang L
J Virol; 2007 Jun; 81(11):6068-78. PubMed ID: 17376914
[TBL] [Abstract][Full Text] [Related]
32. Functional dissection of human targets for KSHV-encoded miRNAs using network analysis.
Wang Y; Lin Y; Guo Y; Pu X; Li M
Sci Rep; 2017 Jun; 7(1):3159. PubMed ID: 28600495
[TBL] [Abstract][Full Text] [Related]
33. Persistent KSHV Infection Increases EBV-Associated Tumor Formation In Vivo via Enhanced EBV Lytic Gene Expression.
McHugh D; Caduff N; Barros MHM; Rämer PC; Raykova A; Murer A; Landtwing V; Quast I; Styles CT; Spohn M; Fowotade A; Delecluse HJ; Papoudou-Bai A; Lee YM; Kim JM; Middeldorp J; Schulz TF; Cesarman E; Zbinden A; Capaul R; White RE; Allday MJ; Niedobitek G; Blackbourn DJ; Grundhoff A; Münz C
Cell Host Microbe; 2017 Jul; 22(1):61-73.e7. PubMed ID: 28704654
[TBL] [Abstract][Full Text] [Related]
34. miRNA Sequence Analysis in Patients With Kaposi's Sarcoma-Associated Herpesvirus.
Tuncer SB; Celik B; Akdeniz Odemis D; Kılıc Erciyas S; Sukruoglu Erdogan O; Avsar M; Kuru Turkcan G; Yazici H
Pathol Oncol Res; 2022; 28():1610055. PubMed ID: 35140551
[TBL] [Abstract][Full Text] [Related]
35. Cloning and identification of a microRNA cluster within the latency-associated region of Kaposi's sarcoma-associated herpesvirus.
Samols MA; Hu J; Skalsky RL; Renne R
J Virol; 2005 Jul; 79(14):9301-5. PubMed ID: 15994824
[TBL] [Abstract][Full Text] [Related]
36. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
[TBL] [Abstract][Full Text] [Related]
37. γ-Herpesvirus-encoded miRNAs and their roles in viral biology and pathogenesis.
Zhu Y; Haecker I; Yang Y; Gao SJ; Renne R
Curr Opin Virol; 2013 Jun; 3(3):266-75. PubMed ID: 23743127
[TBL] [Abstract][Full Text] [Related]
38. [Replication Machinery of Kaposi's Sarcoma-associated Herpesvirus and Drug Discovery Research].
Watanabe T; Fujimuro M
Yakugaku Zasshi; 2019; 139(1):69-73. PubMed ID: 30606932
[TBL] [Abstract][Full Text] [Related]
39. Kaposi's sarcoma-associated herpesvirus microRNAs repress breakpoint cluster region protein expression, enhance Rac1 activity, and increase in vitro angiogenesis.
Ramalingam D; Happel C; Ziegelbauer JM
J Virol; 2015 Apr; 89(8):4249-61. PubMed ID: 25631082
[TBL] [Abstract][Full Text] [Related]
40. A Toolbox for Herpesvirus miRNA Research: Construction of a Complete Set of KSHV miRNA Deletion Mutants.
Jain V; Plaisance-Bonstaff K; Sangani R; Lanier C; Dolce A; Hu J; Brulois K; Haecker I; Turner P; Renne R; Krueger B
Viruses; 2016 Feb; 8(2):. PubMed ID: 26907327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
